Stockreport

Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF pocket, reversible pan-KRAS inhibitor—Erasca says the orthogonal mechanisms give the company optionality across tumor types and future combinations. ERAS-0015 shows a [Read more]